The Scotts Miracle-Gro Company
US ˙ NYSE ˙ US8101861065

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Michael E Porter. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Michael E Porter har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:MACK / Merrimack Pharmaceuticals, Inc. Director 7.500
US:PTC / PTC Inc. Director 0
US:SMG / The Scotts Miracle-Gro Company Director 0
US:TMO / Thermo Fisher Scientific Inc. Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Michael E Porter. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb SMG / The Scotts Miracle-Gro Company – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SMG / The Scotts Miracle-Gro Company. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-08-15 SMG PORTER MICHAEL E 810 56,8900 810 56,8900 46.081 215 68.9900 9.802 21,27
2013-05-14 SMG PORTER MICHAEL E 500 48,2500 500 48,2500 24.125
2013-05-10 SMG PORTER MICHAEL E 1.000 47,8800 1.000 47,8800 47.880

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SMG / The Scotts Miracle-Gro Company Insider Trades
Insidersalg SMG / The Scotts Miracle-Gro Company – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SMG / The Scotts Miracle-Gro Company. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SMG / The Scotts Miracle-Gro Company Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Michael E Porter som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2017-09-15 2017-09-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 7.500 7.500
2017-03-13 2017-03-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -25.000 0 -100,00
2017-03-13 2017-03-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -60.000 0 -100,00
2017-03-13 2017-03-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 85.000 839.448 11,27 2,69 228.650 2.258.115
2016-06-16 2016-06-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 43.000 43.000
2016-03-21 2016-03-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 754.448 0,67 7,20 36.000 5.432.026
2016-03-17 2016-03-15 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 749.448 0,67 7,65 38.250 5.733.277
2016-03-10 2016-03-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10.000 744.448 1,36 7,09 70.900 5.278.136
2016-03-04 2016-03-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10.000 734.448 1,38 6,27 62.700 4.604.989
2016-03-04 2016-03-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 724.448 0,69 6,63 33.150 4.803.090
2016-03-02 2016-03-01 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10.000 719.448 1,41 6,60 66.000 4.748.357
2016-03-02 2016-02-29 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10.000 709.448 1,43 5,61 56.100 3.980.003
2015-08-25 2015-08-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 699.448 0,72 9,76 48.800 6.826.612
2015-08-17 2015-08-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3.000 694.448 0,43 10,18 30.540 7.069.481
2015-08-17 2015-08-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10.000 691.448 1,47 10,65 106.500 7.363.921
2015-08-13 2015-08-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 20.000 681.448 3,02 10,16 203.200 6.923.512
2015-05-18 2015-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 14.000 14.000
2015-05-15 2015-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 8.284 661.448 1,27 11,79 97.668 7.798.472
2015-03-26 2015-03-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 653.164 0,77 11,70 58.500 7.642.019
2015-03-24 2015-03-20 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 648.164 0,78 11,77 58.850 7.628.890
2015-03-19 2015-03-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift -1.190 643.164 -0,18
2015-03-19 2015-03-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1.190 644.354 0,19 11,77 14.006 7.584.047
2015-03-13 2015-03-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 643.164 0,78 11,33 56.650 7.287.048
2015-03-05 2015-03-04 4 PTC PTC INC.
Restricted Stock Units
M - Exercise -3.106 0 -100,00
2015-03-05 2015-03-04 4 PTC PTC INC.
Restricted Stock Units
M - Exercise -6.028 0 -100,00
2015-03-05 2015-03-04 4 PTC PTC INC.
Common Stock
M - Exercise 9.134 231.599 4,11
2015-03-04 2015-03-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 638.164 0,79 10,93 54.650 6.975.133
2015-02-02 2015-01-29 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
M - Exercise -1.082 0 -100,00
2015-02-02 2015-01-29 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
M - Exercise -1.932 0 -100,00
2015-02-02 2015-01-29 4 SMG SCOTTS MIRACLE-GRO CO
Common Shares
M - Exercise 3.014 22.204 15,71
2014-12-12 2014-12-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 8 1.082 0,74 61,86 495 66.933
2014-12-12 2014-12-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 14 1.932 0,73 61,86 866 119.514
2014-12-12 2014-12-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 1 111 0,91 61,86 62 6.866
2014-12-12 2014-12-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 17 2.318 0,74 61,86 1.052 143.391
2014-12-04 2014-12-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 8.000 633.164 1,28 8,71 69.680 5.514.858
2014-11-24 2014-11-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.675 625.164 0,92 9,00 51.075 5.626.476
2014-11-24 2014-11-20 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 6.234 619.489 1,02 8,76 54.610 5.426.724
2014-11-18 2014-11-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 613.255 0,82 8,29 41.450 5.083.884
2014-11-17 2014-11-15 4 PTC PTC INC.
Restricted Stock Units
M - Exercise -3.107 3.106 -50,01
2014-11-17 2014-11-15 4 PTC PTC INC.
Common Stock
M - Exercise 3.107 222.465 1,42
2014-11-13 2014-11-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 40.000 608.255 7,04 8,37 334.800 5.091.094
2014-10-24 2014-10-22 4 SMG SCOTTS MIRACLE-GRO CO
Stock Option (right to buy)
J - Other 456 9.156 5,24
2014-10-24 2014-10-22 4 SMG SCOTTS MIRACLE-GRO CO
Stock Option (right to buy)
J - Other 571 11.562 5,20
2014-09-19 2014-09-17 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 37 1.074 3,57 56,41 2.087 60.584
2014-09-19 2014-09-17 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 66 1.918 3,56 56,41 3.723 108.194
2014-09-19 2014-09-17 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 4 110 3,77 56,41 226 6.205
2014-09-19 2014-09-17 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 79 2.301 3,56 56,41 4.456 129.799
2014-09-12 2014-09-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 8 1.037 0,78 56,65 453 58.746
2014-09-12 2014-09-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 15 1.852 0,82 56,65 850 104.916
2014-09-12 2014-09-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 1 106 0,95 56,65 57 6.005
2014-09-12 2014-09-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 18 2.222 0,82 56,65 1.020 125.876
2014-08-19 2014-08-15 4 SMG SCOTTS MIRACLE-GRO CO
Common Shares
P - Purchase 810 19.190 4,41 56,89 46.081 1.091.719
2014-06-24 2014-06-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 32.390 568.255 6,04 6,84 221.548 3.886.864
2014-06-12 2014-06-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 7 1.029 0,68 60,83 426 62.594
2014-06-12 2014-06-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 13 1.837 0,71 60,83 791 111.745
2014-06-12 2014-06-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 1 105 0,96 60,83 61 6.387
2014-06-12 2014-06-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 16 2.204 0,73 60,83 973 134.069
2014-05-16 2014-05-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 535.865 0,94 6,50 32.500 3.483.122
2014-05-16 2014-05-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10.000 530.865 1,92 6,49 64.900 3.445.314
2014-05-15 2014-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 30.268 30.268
2014-05-09 2014-05-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -5.000 0 -100,00
2014-05-09 2014-05-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2.500 0 -100,00
2014-05-09 2014-05-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2.500 0 -100,00
2014-05-09 2014-05-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2014-05-09 2014-05-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 520.865 0,97 6,48 32.400 3.375.205
2014-05-09 2014-05-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 5.000 515.865 0,98 2,12 10.600 1.093.634
2014-05-09 2014-05-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 2.500 510.865 0,49 1,81 4.525 924.666
2014-05-09 2014-05-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 2.500 508.365 0,49 2,59 6.475 1.316.665
2014-05-09 2014-05-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 505.865 2,02 1,71 17.100 865.029
2014-05-09 2014-05-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 495.865 1,02 6,70 33.500 3.322.296
2014-05-07 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 490.865 1,03 6,12 30.600 3.004.094
2014-05-05 2014-05-01 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 1.022 1.022
2014-05-05 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 15.000 485.865 3,19 6,41 96.150 3.114.395
2014-03-12 2014-03-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 13 1.824 0,72 59,57 774 108.656
2014-03-12 2014-03-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 1 104 0,97 59,57 60 6.195
2014-03-12 2014-03-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 16 2.188 0,74 59,57 953 130.339
2014-03-07 2014-03-05 4 PTC PTC INC.
Restricted Stock Units
A - Award 6.028 6.028
2014-03-07 2014-03-05 4 PTC PTC INC.
Restricted Stock Units
M - Exercise -8.779 0 -100,00
2014-03-07 2014-03-05 4 PTC PTC INC.
Common Stock
M - Exercise 8.779 219.358 4,17
2014-02-14 2014-02-12 4 PTC PTC INC.
Employee Stock Option
M - Exercise -10.000 0 -100,00
2014-02-14 2014-02-12 4 PTC PTC INC.
Common Stock
S - Sale -10.000 210.579 -4,53 37,18 -371.775 7.828.801
2014-02-14 2014-02-12 4 PTC PTC INC.
Common Stock
M - Exercise 10.000 220.579 4,75 11,48 114.750 2.531.144
2014-02-04 2014-01-31 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 1.811 1.811
2013-12-18 2013-12-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 12.500 470.865 2,73 4,80 59.939 2.257.845
2013-12-18 2013-12-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 12.500 458.365 2,80 4,71 58.872 2.158.807
2013-12-12 2013-12-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 1 103 0,98 59,63 60 6.142
2013-12-12 2013-12-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 16 2.172 0,74 59,63 954 129.516
2013-12-11 2013-12-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 18.000 445.865 4,21 4,38 78.840 1.952.889
2013-12-04 2013-12-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 427.865 1,18 4,25 21.252 1.818.640
2013-12-04 2013-12-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 70.000 422.865 19,84 4,17 291.655 1.761.867
2013-12-02 2013-11-27 4 PMTC PTC INC.
Restricted Stock Units
A - Award 6.213 6.213
2013-12-02 2013-11-29 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 25.000 352.865 7,63 3,79 94.830 1.338.488
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 50.000 327.865 17,99 3,51 175.355 1.149.855
2013-09-12 2013-09-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 1 102 0,99 55,07 55 5.617
2013-09-12 2013-09-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 17 2.156 0,79 55,07 936 118.731
2013-08-06 2013-08-02 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 101 101
2013-06-13 2013-06-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 30.268 30.268
2013-06-12 2013-06-10 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 15 2.139 0,71 47,20 708 100.961
2013-05-14 2013-05-14 4 SMG SCOTTS MIRACLE-GRO CO
Common Shares
P - Purchase 500 18.380 2,80 48,25 24.125 886.835
2013-05-14 2013-05-10 4 SMG SCOTTS MIRACLE-GRO CO
Common Shares
P - Purchase 1.000 17.880 5,92 47,88 47.880 856.094
2013-03-12 2013-03-08 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 15 2.124 0,71 46,73 701 99.255
2013-03-08 2013-03-06 4 PMTC PTC INC.
Restricted Stock Units
A - Award 8.779 8.779
2013-01-29 2013-01-28 4 PMTC PTC INC.
Employee Stock Option
M - Exercise -10.000 0 -100,00
2013-01-29 2013-01-28 4 PMTC PTC INC.
Common Stock
S - Sale -10.000 210.579 -4,53 23,56 -235.610 4.961.452
2013-01-29 2013-01-28 4 PMTC PTC INC.
Common Stock
M - Exercise 10.000 220.579 4,75 4,98 49.750 1.097.381
2013-01-23 2013-01-18 4 SMG SCOTTS MIRACLE-GRO CO
Deferred Stock Units
A - Award 2.109 2.109
2013-01-23 3 SMG SCOTTS MIRACLE-GRO CO
Common Shares
16.880
2012-12-18 2012-12-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -15.000 0 -100,00
2012-12-18 2012-12-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 15.000 277.865 5,71 2,19 32.850 608.524
2012-12-12 2012-12-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10.000 262.865 3,95 6,08 60.800 1.598.219
2012-08-27 2012-08-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 21.300 21.300
2012-05-30 2012-05-29 4 PMTC PARAMETRIC TECHNOLOGY CORP
Employee Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2012-05-30 2012-05-29 4 PMTC PARAMETRIC TECHNOLOGY CORP
Common Stock
S - Sale -10.000 210.579 -4,53 20,59 -205.927 4.336.390
2012-05-30 2012-05-29 4 PMTC PARAMETRIC TECHNOLOGY CORP
Common Stock
M - Exercise 10.000 220.579 4,75 8,50 85.000 1.874.922
2012-05-25 2012-05-23 4 PMTC PARAMETRIC TECHNOLOGY CORP
Employee Stock Option (right to buy)
M - Exercise -10.000 10.000 -50,00
2012-05-25 2012-05-23 4 PMTC PARAMETRIC TECHNOLOGY CORP
Common Stock
S - Sale -10.000 210.579 -4,53 19,98 -199.831 4.208.021
2012-05-25 2012-05-23 4 PMTC PARAMETRIC TECHNOLOGY CORP
Common Stock
M - Exercise 10.000 220.579 4,75 8,50 85.000 1.874.922
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -28.570 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -33.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -25.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -34.286 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -56.509 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 28.570 252.865 12,74
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 33.000 224.295 17,25
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 25.000 191.295 15,03
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 34.286 166.295 25,97
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 56.509 132.009 74,85
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 12.500 75.500 19,84 7,00 87.500 528.500
2012-03-12 2012-03-09 4 TMO THERMO FISHER SCIENTIFIC INC.
Stock Option (Right to Buy)
M - Exercise -3.750 0 -100,00
2012-03-12 2012-03-09 4 TMO THERMO FISHER SCIENTIFIC INC.
Common Stock
S - Sale -300 14.640 -2,01 56,43 -16.929 826.135
2012-03-12 2012-03-09 4 TMO THERMO FISHER SCIENTIFIC INC.
Common Stock
S - Sale -756 14.940 -4,82 56,42 -42.654 842.915
2012-03-12 2012-03-09 4 TMO THERMO FISHER SCIENTIFIC INC.
Common Stock
S - Sale -2.694 15.696 -14,65 56,41 -151.969 885.411
2012-03-12 2012-03-09 4 TMO THERMO FISHER SCIENTIFIC INC.
Common Stock
M - Exercise 3.750 18.390 25,61 26,53 99.488 487.887
2012-03-12 2012-03-08 4 TMO THERMO FISHER SCIENTIFIC INC.
Stock Option (Right to Buy)
M - Exercise -3.750 3.750 -50,00
2012-03-12 2012-03-08 4 TMO THERMO FISHER SCIENTIFIC INC.
Common Stock
S - Sale -3.750 14.640 -20,39 56,05 -210.188 820.572
2012-03-12 2012-03-08 4 TMO THERMO FISHER SCIENTIFIC INC.
Common Stock
M - Exercise 3.750 18.390 25,61 26,53 99.488 487.887
2012-03-08 2012-03-07 4 PMTC PARAMETRIC TECHNOLOGY CORP
Common Stock
A - Award 7.479 210.579 3,68
2012-02-01 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
63.000
2007-09-20 2007-09-19 4 PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise -12.000 0 -100,00
2007-09-20 2007-09-19 4 PMTC PARAMETRIC TECHNOLOGY CORP
Common Stock
M - Exercise 12.000 124.788 10,64 5,25 63.000 655.137
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 10.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 10.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 12.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 20.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 60.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 8.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 6.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 24.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 6.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 6.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 12.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 4.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 19.200 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 20.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Stock Option (right to buy)
M - Exercise 0 4.000 0,00
2006-03-02 2006-03-01 4/A PMTC PARAMETRIC TECHNOLOGY CORP
Common Stock
A - Award 12.000 100.400 13,57
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)